Guggenheim Maintains Buy on Xponential Fitness, Lowers Price Target to $10
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Guggenheim analyst John Heinbockel maintains Xponential Fitness (NYSE:XPOF) with a Buy and lowers the price target from $12 to $10.
Guggenheim analyst John Heinbockel maintains Xponential Fitness (NYSE:XPOF) with a Buy and lowers the price target from $12 to $10.